A second check you can run yourself.
Many hospital systems already flag interactions inside the patient chart. Caydra is a standalone assistant for licensed clinicians: enter the list, see colors and source notes when available, then keep your own judgment. No hospital IT ticket. Clinician beta opened August 25, 2026 — United States and Canada.
U.S. emergency visits each year from adverse drug events (ADEs)
of those visits lead to hospitalization
Source: CDC, FastStats: Medication Safety Data, April 17, 2024. cdc.gov/medication-safety/data-research/facts-stats. These are national figures, not Caydra results. Caydra does not claim to reduce these national figures. CDC defines an ADE as harm from a medicine (allergic reaction, side effect, overmedication, or medication error). Caydra assists licensed clinicians. It does not replace your judgment.
Caydra’s drug name list is built from RxNorm (U.S. National Library of Medicine): 14,000+ U.S. medication names clinicians can search. Source: NIH RxNorm. This describes our name list, not a claim that every drug pair has been scored. Methods and citations: Sources.
Built for the desk, not the install project
Independent and small-clinic clinicians in the United States and Canada can request the beta this month. Minutes, not months. You choose the list. You see why a color was assigned.
Colors so you can compare, not drown
Red is not mixed with mild noise. Gray means not in our evidence set yet — missing is not “safe.” If a color looks wrong, tell us. We review feedback and update when we can.